Report cover image

Global Morphine Hydrochloride Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 190 Pages
SKU # APRC20360823

Description

Summary

According to APO Research, the global Morphine Hydrochloride market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Morphine Hydrochloride is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Morphine Hydrochloride is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Morphine Hydrochloride market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Morphine Hydrochloride is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Morphine Hydrochloride market include Tocris Bioscience, Taj Pharmaceuticals Limited, R&D Systems, LoGiCal and Alcaliber, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Morphine Hydrochloride, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Morphine Hydrochloride, also provides the sales of main regions and countries. Of the upcoming market potential for Morphine Hydrochloride, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Morphine Hydrochloride sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Morphine Hydrochloride market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Morphine Hydrochloride sales, projected growth trends, production technology, application and end-user industry.

Morphine Hydrochloride Segment by Company

Tocris Bioscience
Taj Pharmaceuticals Limited
R&D Systems
LoGiCal
Alcaliber
Morphine Hydrochloride Segment by Type

Injection
Pill
Oral Drops
Others
Morphine Hydrochloride Segment by Application

Anesthesia
Analgesic
Morphine Hydrochloride Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Morphine Hydrochloride status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Morphine Hydrochloride market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Morphine Hydrochloride significant trends, drivers, influence factors in global and regions.
6. To analyze Morphine Hydrochloride competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Morphine Hydrochloride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Morphine Hydrochloride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Morphine Hydrochloride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Morphine Hydrochloride market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Morphine Hydrochloride industry.
Chapter 3: Detailed analysis of Morphine Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Morphine Hydrochloride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Morphine Hydrochloride in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Table of Contents

190 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Morphine Hydrochloride Sales Value (2020-2031)
1.2.2 Global Morphine Hydrochloride Sales Volume (2020-2031)
1.2.3 Global Morphine Hydrochloride Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Morphine Hydrochloride Market Dynamics
2.1 Morphine Hydrochloride Industry Trends
2.2 Morphine Hydrochloride Industry Drivers
2.3 Morphine Hydrochloride Industry Opportunities and Challenges
2.4 Morphine Hydrochloride Industry Restraints
3 Morphine Hydrochloride Market by Company
3.1 Global Morphine Hydrochloride Company Revenue Ranking in 2024
3.2 Global Morphine Hydrochloride Revenue by Company (2020-2025)
3.3 Global Morphine Hydrochloride Sales Volume by Company (2020-2025)
3.4 Global Morphine Hydrochloride Average Price by Company (2020-2025)
3.5 Global Morphine Hydrochloride Company Ranking (2023-2025)
3.6 Global Morphine Hydrochloride Company Manufacturing Base and Headquarters
3.7 Global Morphine Hydrochloride Company Product Type and Application
3.8 Global Morphine Hydrochloride Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Morphine Hydrochloride Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Morphine Hydrochloride Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Morphine Hydrochloride Market by Type
4.1 Morphine Hydrochloride Type Introduction
4.1.1 Injection
4.1.2 Pill
4.1.3 Oral Drops
4.1.4 Others
4.2 Global Morphine Hydrochloride Sales Volume by Type
4.2.1 Global Morphine Hydrochloride Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Morphine Hydrochloride Sales Volume by Type (2020-2031)
4.2.3 Global Morphine Hydrochloride Sales Volume Share by Type (2020-2031)
4.3 Global Morphine Hydrochloride Sales Value by Type
4.3.1 Global Morphine Hydrochloride Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Morphine Hydrochloride Sales Value by Type (2020-2031)
4.3.3 Global Morphine Hydrochloride Sales Value Share by Type (2020-2031)
5 Morphine Hydrochloride Market by Application
5.1 Morphine Hydrochloride Application Introduction
5.1.1 Anesthesia
5.1.2 Analgesic
5.2 Global Morphine Hydrochloride Sales Volume by Application
5.2.1 Global Morphine Hydrochloride Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Morphine Hydrochloride Sales Volume by Application (2020-2031)
5.2.3 Global Morphine Hydrochloride Sales Volume Share by Application (2020-2031)
5.3 Global Morphine Hydrochloride Sales Value by Application
5.3.1 Global Morphine Hydrochloride Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Morphine Hydrochloride Sales Value by Application (2020-2031)
5.3.3 Global Morphine Hydrochloride Sales Value Share by Application (2020-2031)
6 Morphine Hydrochloride Regional Sales and Value Analysis
6.1 Global Morphine Hydrochloride Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Morphine Hydrochloride Sales by Region (2020-2031)
6.2.1 Global Morphine Hydrochloride Sales by Region: 2020-2025
6.2.2 Global Morphine Hydrochloride Sales by Region (2026-2031)
6.3 Global Morphine Hydrochloride Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Morphine Hydrochloride Sales Value by Region (2020-2031)
6.4.1 Global Morphine Hydrochloride Sales Value by Region: 2020-2025
6.4.2 Global Morphine Hydrochloride Sales Value by Region (2026-2031)
6.5 Global Morphine Hydrochloride Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Morphine Hydrochloride Sales Value (2020-2031)
6.6.2 North America Morphine Hydrochloride Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Morphine Hydrochloride Sales Value (2020-2031)
6.7.2 Europe Morphine Hydrochloride Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Morphine Hydrochloride Sales Value (2020-2031)
6.8.2 Asia-Pacific Morphine Hydrochloride Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Morphine Hydrochloride Sales Value (2020-2031)
6.9.2 South America Morphine Hydrochloride Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Morphine Hydrochloride Sales Value (2020-2031)
6.10.2 Middle East & Africa Morphine Hydrochloride Sales Value Share by Country, 2024 VS 2031
7 Morphine Hydrochloride Country-level Sales and Value Analysis
7.1 Global Morphine Hydrochloride Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Morphine Hydrochloride Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Morphine Hydrochloride Sales by Country (2020-2031)
7.3.1 Global Morphine Hydrochloride Sales by Country (2020-2025)
7.3.2 Global Morphine Hydrochloride Sales by Country (2026-2031)
7.4 Global Morphine Hydrochloride Sales Value by Country (2020-2031)
7.4.1 Global Morphine Hydrochloride Sales Value by Country (2020-2025)
7.4.2 Global Morphine Hydrochloride Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Morphine Hydrochloride Sales Value Growth Rate (2020-2031)
7.5.2 USA Morphine Hydrochloride Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Morphine Hydrochloride Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Morphine Hydrochloride Sales Value Growth Rate (2020-2031)
7.6.2 Canada Morphine Hydrochloride Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Morphine Hydrochloride Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Morphine Hydrochloride Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Morphine Hydrochloride Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Morphine Hydrochloride Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Morphine Hydrochloride Sales Value Growth Rate (2020-2031)
7.8.2 Germany Morphine Hydrochloride Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Morphine Hydrochloride Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Morphine Hydrochloride Sales Value Growth Rate (2020-2031)
7.9.2 France Morphine Hydrochloride Sales Value Share by Type, 2024 VS 2031
7.9.3 France Morphine Hydrochloride Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Morphine Hydrochloride Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Morphine Hydrochloride Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Morphine Hydrochloride Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Morphine Hydrochloride Sales Value Growth Rate (2020-2031)
7.11.2 Italy Morphine Hydrochloride Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Morphine Hydrochloride Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Morphine Hydrochloride Sales Value Growth Rate (2020-2031)
7.12.2 Spain Morphine Hydrochloride Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Morphine Hydrochloride Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Morphine Hydrochloride Sales Value Growth Rate (2020-2031)
7.13.2 Russia Morphine Hydrochloride Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Morphine Hydrochloride Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Morphine Hydrochloride Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Morphine Hydrochloride Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Morphine Hydrochloride Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Morphine Hydrochloride Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Morphine Hydrochloride Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Morphine Hydrochloride Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Morphine Hydrochloride Sales Value Growth Rate (2020-2031)
7.16.2 China Morphine Hydrochloride Sales Value Share by Type, 2024 VS 2031
7.16.3 China Morphine Hydrochloride Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Morphine Hydrochloride Sales Value Growth Rate (2020-2031)
7.17.2 Japan Morphine Hydrochloride Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Morphine Hydrochloride Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Morphine Hydrochloride Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Morphine Hydrochloride Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Morphine Hydrochloride Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Morphine Hydrochloride Sales Value Growth Rate (2020-2031)
7.19.2 India Morphine Hydrochloride Sales Value Share by Type, 2024 VS 2031
7.19.3 India Morphine Hydrochloride Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Morphine Hydrochloride Sales Value Growth Rate (2020-2031)
7.20.2 Australia Morphine Hydrochloride Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Morphine Hydrochloride Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Morphine Hydrochloride Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Morphine Hydrochloride Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Morphine Hydrochloride Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Morphine Hydrochloride Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Morphine Hydrochloride Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Morphine Hydrochloride Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Morphine Hydrochloride Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Morphine Hydrochloride Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Morphine Hydrochloride Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Morphine Hydrochloride Sales Value Growth Rate (2020-2031)
7.24.2 Chile Morphine Hydrochloride Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Morphine Hydrochloride Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Morphine Hydrochloride Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Morphine Hydrochloride Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Morphine Hydrochloride Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Morphine Hydrochloride Sales Value Growth Rate (2020-2031)
7.26.2 Peru Morphine Hydrochloride Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Morphine Hydrochloride Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Morphine Hydrochloride Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Morphine Hydrochloride Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Morphine Hydrochloride Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Morphine Hydrochloride Sales Value Growth Rate (2020-2031)
7.28.2 Israel Morphine Hydrochloride Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Morphine Hydrochloride Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Morphine Hydrochloride Sales Value Growth Rate (2020-2031)
7.29.2 UAE Morphine Hydrochloride Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Morphine Hydrochloride Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Morphine Hydrochloride Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Morphine Hydrochloride Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Morphine Hydrochloride Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Morphine Hydrochloride Sales Value Growth Rate (2020-2031)
7.31.2 Iran Morphine Hydrochloride Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Morphine Hydrochloride Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Morphine Hydrochloride Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Morphine Hydrochloride Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Morphine Hydrochloride Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Tocris Bioscience
8.1.1 Tocris Bioscience Comapny Information
8.1.2 Tocris Bioscience Business Overview
8.1.3 Tocris Bioscience Morphine Hydrochloride Sales, Value and Gross Margin (2020-2025)
8.1.4 Tocris Bioscience Morphine Hydrochloride Product Portfolio
8.1.5 Tocris Bioscience Recent Developments
8.2 Taj Pharmaceuticals Limited
8.2.1 Taj Pharmaceuticals Limited Comapny Information
8.2.2 Taj Pharmaceuticals Limited Business Overview
8.2.3 Taj Pharmaceuticals Limited Morphine Hydrochloride Sales, Value and Gross Margin (2020-2025)
8.2.4 Taj Pharmaceuticals Limited Morphine Hydrochloride Product Portfolio
8.2.5 Taj Pharmaceuticals Limited Recent Developments
8.3 R&D Systems
8.3.1 R&D Systems Comapny Information
8.3.2 R&D Systems Business Overview
8.3.3 R&D Systems Morphine Hydrochloride Sales, Value and Gross Margin (2020-2025)
8.3.4 R&D Systems Morphine Hydrochloride Product Portfolio
8.3.5 R&D Systems Recent Developments
8.4 LoGiCal
8.4.1 LoGiCal Comapny Information
8.4.2 LoGiCal Business Overview
8.4.3 LoGiCal Morphine Hydrochloride Sales, Value and Gross Margin (2020-2025)
8.4.4 LoGiCal Morphine Hydrochloride Product Portfolio
8.4.5 LoGiCal Recent Developments
8.5 Alcaliber
8.5.1 Alcaliber Comapny Information
8.5.2 Alcaliber Business Overview
8.5.3 Alcaliber Morphine Hydrochloride Sales, Value and Gross Margin (2020-2025)
8.5.4 Alcaliber Morphine Hydrochloride Product Portfolio
8.5.5 Alcaliber Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Morphine Hydrochloride Value Chain Analysis
9.1.1 Morphine Hydrochloride Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Morphine Hydrochloride Sales Mode & Process
9.2 Morphine Hydrochloride Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Morphine Hydrochloride Distributors
9.2.3 Morphine Hydrochloride Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.